EVALUATION OF CITALOPRAM AFFECTED THE GENERALIZED ANXIETY DISORDER PARTICIPANTS’ QUALITY OF LIFE. Int. Res. J. Pharm. [Internet]. 2023 Nov. 30 [cited 2026 May 26];14(11):21-5. Available from: https://irjponline.org/index.php/irjp/article/view/3480